| Bioactivity | Pharmacokinetic studies of Cefonicid monosodium have shown that high blood concentrations can be achieved rapidly after intravenous and intramuscular injection, and that concomitant use of albendazole prolongs its half-life in the body and reduces the rate of renal excretion[1]. |
| CAS | 71420-79-6 |
| Formula | C18H17N6NaO8S3 |
| Molar Mass | 564.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Pitkin D, et al. Kinetics and renal handling of cefonicid[J]. Clinical Pharmacology & Therapeutics, 1981, 30(5): 587-593. |
Cefonicid monosodium
CAS: 71420-79-6 F: C18H17N6NaO8S3 W: 564.55
Pharmacokinetic studies of Cefonicid monosodium have shown that high blood concentrations can be achieved rapidly after
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.